Login to Your Account



Thriving in 2008: Approvals, Deals and Other Silver Linings

By Donna Young and Trista Morrison


Monday, January 5, 2009
The year 2008 in biotechnology will be remembered as one of survival, including restructurings and layoffs at more than 80 companies, executive pay-cuts and resignations, discontinued programs, and lots of asset monetization and creative financing. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription